These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 22544533)

  • 1. Allogeneic hematopoietic stem cell transplantation in children with sickle cell disease.
    Locatelli F; Pagliara D
    Pediatr Blood Cancer; 2012 Aug; 59(2):372-6. PubMed ID: 22544533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem-cell transplantation in children and adults with sickle cell disease: an update.
    Khoury R; Abboud MR
    Expert Rev Hematol; 2011 Jun; 4(3):343-51. PubMed ID: 21668398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell transplantation after reduced-intensity conditioning for sickle cell disease.
    Matthes-Martin S; Lawitschka A; Fritsch G; Lion T; Grimm B; Breuer S; Boztug H; Karlhuber S; Holter W; Peters C; Minkov M
    Eur J Haematol; 2013 Apr; 90(4):308-12. PubMed ID: 23369103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell transplantation for sickle cell disease: can we reduce the toxicity?
    Fixler J; Vichinsky E; Walters MC
    Pediatr Pathol Mol Med; 2001; 20(1):73-86. PubMed ID: 12673845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonmyeloablative approaches to the treatment of sickle hemoglobinopathies.
    Amado RG; Schiller GJ
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):82-9. PubMed ID: 10877059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies.
    Pedrazzoli P; Da Prada GA; Giorgiani G; Schiavo R; Zambelli A; Giraldi E; Landonio G; Locatelli F; Siena S; Della Cuna GR
    Cancer; 2002 May; 94(9):2409-15. PubMed ID: 12015766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Will developments in allogeneic transplantation influence treatment of adult patients with sickle cell disease?
    Chakrabarti S; Bareford D
    Biol Blood Marrow Transplant; 2004 Jan; 10(1):23-31. PubMed ID: 14752776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease.
    van Besien K; Bartholomew A; Stock W; Peace D; Devine S; Sher D; Sosman J; Chen YH; Koshy M; Hoffman R
    Bone Marrow Transplant; 2000 Aug; 26(4):445-9. PubMed ID: 10982293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplantation of unrelated placental blood cells in children with high-risk sickle cell disease.
    Adamkiewicz TV; Mehta PS; Boyer MW; Kedar A; Olson TA; Olson E; Chiang KY; Maurer D; Mogul MJ; Wingard JR; Yeager AM
    Bone Marrow Transplant; 2004 Sep; 34(5):405-11. PubMed ID: 15247929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in allogeneic stem cell transplantation for hemoglobinopathies.
    Al Jefri AH
    Hemoglobin; 2011; 35(5-6):469-75. PubMed ID: 21967642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of autologous and allogeneic hematopoietic stem cell transplantation for 140 patients with de novo acute leukemia in first complete remission].
    Wang HH; Feng SZ; Wang M; Wei JL; Jiang EL; Zhang L; Huang Y; Zhou SY; Liu QG; Qiu LG; Han MZ; Yan WW
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):389-92. PubMed ID: 15355688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curative therapies: Allogeneic hematopoietic cell transplantation from matched related donors using myeloablative, reduced intensity, and nonmyeloablative conditioning in sickle cell disease.
    Guilcher GMT; Truong TH; Saraf SL; Joseph JJ; Rondelli D; Hsieh MM
    Semin Hematol; 2018 Apr; 55(2):87-93. PubMed ID: 29958564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxyurea treatment for sickle cell disease: impact on haematopoietic stem cell transplantation's outcome.
    Brachet C; Azzi N; Demulder A; Devalck C; Gourdin A; Gulbis B; Klein A; Le PQ; Loop M; Sariban E; Ferster A
    Bone Marrow Transplant; 2004 Apr; 33(8):799-803. PubMed ID: 14767501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.
    Al-Mousa H; Al-Shammari Z; Al-Ghonaium A; Al-Dhekri H; Al-Muhsen S; Al-Saud B; Arnaout R; Al-Seraihy A; Al-Jefri A; Al-Ahmari A; Ayas M; El-Solh H
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):818-23. PubMed ID: 20079864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Allogeneic hematopoietic stem cell transplantation for acute lymphocytic leukemia].
    Chen H; Ren HY; Guo NL; Huang XJ; Liu KY; Xu LP; Zhang YC; Zheng H; Wu T; Liu DH; Yang SM; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):87-90. PubMed ID: 14990046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic cellular gene therapy for hemoglobinopathies.
    Gaziev J; Lucarelli G
    Hematol Oncol Clin North Am; 2010 Dec; 24(6):1145-63. PubMed ID: 21075285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning.
    Servais S; Baron F; Beguin Y
    Transfus Apher Sci; 2011 Apr; 44(2):205-10. PubMed ID: 21345734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning regimen in children: a single-center experience.
    Strullu M; Rialland F; Cahu X; Brissot E; Corradini N; Thomas C; Blin N; Rialland X; Méchinaud F; Mohty M
    Eur J Haematol; 2012 Jun; 88(6):504-9. PubMed ID: 22372430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
    Valcárcel D; Martino R; Sureda A; Canals C; Altés A; Briones J; Sanz MA; Parody R; Constans M; Villela SL; Brunet S; Sierra J
    Eur J Haematol; 2005 Feb; 74(2):144-51. PubMed ID: 15654906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.